Ameritas Investment Partners, Inc. - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 105 filers reported holding TG THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$113,972
-59.5%
13,633
+20.3%
0.01%
-54.5%
Q2 2023$281,462
+79.8%
11,331
+8.9%
0.01%
+83.3%
Q1 2023$156,521
+25.5%
10,407
+5.9%
0.01%
+20.0%
Q4 2022$124,705
+115.0%
9,8270.0%0.01%
+66.7%
Q3 2022$58,000
+41.5%
9,8270.0%0.00%
+50.0%
Q2 2022$41,000
-55.9%
9,8270.0%0.00%
-33.3%
Q1 2022$93,000
-50.3%
9,8270.0%0.00%
-50.0%
Q4 2021$187,000
-42.8%
9,8270.0%0.01%
-50.0%
Q3 2021$327,000
-16.8%
9,827
-3.1%
0.01%
-14.3%
Q2 2021$393,000
-17.6%
10,140
+2.5%
0.01%
-22.2%
Q1 2021$477,000
-5.0%
9,895
+2.5%
0.02%
-21.7%
Q4 2020$502,000
+98.4%
9,657
+2.1%
0.02%
+109.1%
Q3 2020$253,000
+52.4%
9,462
+10.9%
0.01%
+37.5%
Q2 2020$166,000
+127.4%
8,533
+15.3%
0.01%
+100.0%
Q1 2020$73,000
-2.7%
7,400
+9.8%
0.00%
+33.3%
Q4 2019$75,000
+97.4%
6,7400.0%0.00%
+50.0%
Q3 2019$38,000
-34.5%
6,7400.0%0.00%
-33.3%
Q2 2019$58,000
+48.7%
6,740
+37.6%
0.00%
+50.0%
Q1 2019$39,000
+95.0%
4,8980.0%0.00%
+100.0%
Q4 2018$20,000
-25.9%
4,8980.0%0.00%0.0%
Q3 2018$27,000
-57.8%
4,8980.0%0.00%
-66.7%
Q2 2018$64,000
+6.7%
4,898
+15.0%
0.00%0.0%
Q1 2018$60,000
+71.4%
4,2600.0%0.00%
+50.0%
Q4 2017$35,000
-35.2%
4,2600.0%0.00%
-33.3%
Q3 2017$54,000
+25.6%
4,2600.0%0.00%
+50.0%
Q2 2017$43,000
+34.4%
4,260
+56.2%
0.00%0.0%
Q1 2017$32,0002,7280.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
RA Capital Management 8,198,337$33,613,0001.96%
GREAT POINT PARTNERS LLC 3,000,000$12,300,0001.56%
BRIDGER MANAGEMENT, LLC 3,791,531$15,545,0001.30%
Avoro Capital Advisors LLC 4,750,000$19,475,0001.16%
Opaleye Management Inc. 550,000$2,255,0000.84%
CREDIT AGRICOLE S A 1,307,428$5,360,0000.30%
Eversept Partners, LP 65,000$266,5000.14%
HIGHLAND CAPITAL MANAGEMENT LP 453,360$1,859,0000.14%
683 Capital Management, LLC 500,000$2,050,0000.12%
Artal Group S.A. 400,000$1,640,0000.06%
View complete list of TG THERAPEUTICS INC shareholders